07 Jul 2021 --- Biotech company Inbiose has applied for Generally Recognized as Safe (GRAS) approval by the US Food & Drug Administration (FDA) for four of its human milk oligosaccharides (HMOs). “The four HMOs we submitted for regulatory approval are advanced HMOs that go beyond the current standard HMO 2-fucosyllactose (2’FL) that is currently added to infant formula milk,” Dr. Wim Soetaert, CEO and chairman of Inbiose, tells NutritionInsight.
